Primary Endpoint Both News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Primary Endpoint Both. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Primary Endpoint Both Today - Breaking & Trending Today

AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023

Published: November 7, 2023

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data from its Phase 2 study evaluating dazodalibep, an investigational medicine, for the treatment of...

Source: prnewswire.com

Related Topics:

United StatesThousand OaksPuerto RicoSan DiegoKate MeyerJessica AkopyanDavidm ReeseJustin ClaeysWorld Best CompaniesChemocentryx IncDrug AdministrationBeigene LtdTeneobio IncAmerican College Of RheumatologyKyowa Kirin Co LtdExchange CommissionFirst PhasePrimary Endpoint BothPatients With Severe SymptomatologyWith SystemicFrom Crossover Period Provide Further EvidenceClinical EfficacyAmerican CollegeSevere Systemic DiseaseSyndrome Disease Activity Index